MDS Proteomics opens facility in DenmarkOdensee 20 March 2001 Biotechnology company MDS Proteomics has opened a new facility in Odense, Denmark to house protein discovery factories that seamlessly integrate biology, high performance supercomputing and molecular analysis for the design and development of new medicines. The company is also expanding its Toronto, Canada headquarters and facilities are in development in Boston and Charlottesville.
The new Denmark facility is a major center of expertise for MDS
Proteomics scientists to enhance the understanding of how proteins
function at a cellular level. More than 60 scientists occupy the
30,000 sq. ft. building, which houses a large number of highly
customized mass spectrometers and the 11th largest Linux cluster in
the world, consisting of 101 computers, each with 2 x 1Ghz CPU and 2 GByte
memory.
MDS Proteomics is currently expanding its Toronto presence with a
50,000 sq. ft., state-of-the-art facility for analyzing protein
interaction pathways, producing data for its proprietary BIND database
to select and validate targets for its partners. Informatics research
will be conducted in Toronto, using the world's leading supercomputing
infrastructure, built in collaboration with IBM.
Scientists working in the soon-to-be opened Boston facility will
focus on high throughput screening, structural biology and drug
design, medicinal chemistry and protein identification. This location
also establishes a geographic closeness to Partners Healthcare, which
has collaborated with MDS Proteomics to gain a deeper understanding of
how to utilize the study of protein-to-protein pathways to improve
patient care.
Lastly, MDS Proteomics' Charlottesville facility, located in close
proximity to the University of Virginia, will specialize in the
analysis of complex mixtures of proteins to identify novel membrane
bound receptor proteins as targets for therapeutic drugs.
Ad Emmen |
 |